Ztalmy Suspension
Product Images NDC 81583-100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Ztalmy (NDC 81583-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Immedica Pharma Us Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ztalmy 01)

FDA Label Image

Figure 1 (Ztalmy 02)

FDA Label Image

Image (Ztalmy 03)

FDA Label Image

Image (Ztalmy 04)

Image (Ztalmy 04)
This text is too short and too general to generate a useful description. It appears to be a label or instruction for a product, but without further context, it is not possible to provide any additional information.*
FDA Label Image

Image (Ztalmy 05)

FDA Label Image

Image (Ztalmy 06)

FDA Label Image

Image (Ztalmy 07)

FDA Label Image

Image (Ztalmy 08)

FDA Label Image

Image (Ztalmy 09)

FDA Label Image

Image (Ztalmy 10)

FDA Label Image

Image (Ztalmy 11)

FDA Label Image

Image (Ztalmy 12)

FDA Label Image

Image (Ztalmy 13)

FDA Label Image

Principal Display Panel (50 mg/mL Bottle Label)

Principal Display Panel (50 mg/mL Bottle Label)
This is a description for an oral suspension medication called Ganaxolone, which is used for children and needs to be stored at a temperature of 15°C. The medication should be kept in a dry place, and the cap should remain closed. The recommended dosage is not given, and the reader is referred to the prescribing information from Marinus Pharmaceuticals, Inc. The medication should be administered using the provided syringe, and the shelf life is 30 days after the initial dose.*
FDA Label Image

Principal Display Panel (50 mg/mL Bottle Carton)

Principal Display Panel (50 mg/mL Bottle Carton)
This appears to be a description of a medication called "Ganaxolone", which is an oral suspension with a concentration of 50 mg/mL. The text includes instructions for storage and administration, as well as a warning to read enclosed instructions before use. A pharmacist is also instructed to dispense a medication guide to each patient. No additional information is provided.*
FDA Label Image

Principal Display Panel (50 mg/mL Bottle Carton)

Principal Display Panel (50 mg/mL Bottle Carton)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.